Director at $RGTI sells 100,000 shares in insider sale

A recent SEC filing revealed that Thomas J Iannotti, a director at $RGTI, executed a significant sale of company shares on 09-12-2025, totaling 100,000 shares and amounting to approximately $1,950,020. This transaction represented approximately 87.0% of Iannotti’s shares of this particular class of stock, leaving him with ownership of 14,902 shares in this category of $RGTI stock. The data regarding this sale was obtained from the SEC filing, providing insight into the trading activities of company insiders.

Over the past six months, $RGTI insiders have been actively trading company stock, engaging in a total of 23 transactions on the open market. Interestingly, all 23 of these trades have been sales, with no recorded purchases during this period. Various key figures within the company, including President and CEO Subodh K Kulkarni, have participated in these transactions. Kulkarni sold 1,000,000 shares for an estimated $12,004,400, while Michael S. Clifton completed 7 sales of 300,000 shares, valued at approximately $4,652,490. Similarly, Thomas J Iannotti conducted 2 sales, amounting to 200,000 shares and a total of $3,619,890.

As for hedge fund activity related to $RGTI stock, institutional investors have displayed notable movements in their portfolios. In the most recent quarter, 232 institutional investors increased their holdings of $RGTI stock, while 149 reduced their positions. Major players such as Vanguard Group Inc. added 8,640,470 shares (a 60.9% increase) to their portfolio in Q2 2025, equating to an estimated $102,475,974. On the contrary, UBS Group AG removed 2,406,004 shares (a 60.1% decrease) from their portfolio during the same quarter.

In terms of analyst ratings, Wall Street has been active in evaluating $RGTI stock, with 4 firms issuing buy ratings recently. Notably, Needham issued a “Buy” rating on 08/04/2025, while B. Riley Securities and Cantor Fitzgerald both issued favorable ratings in July of 2025. Benchmark also provided a positive outlook with a “Buy” rating on 05/15/2025. Additionally, various price targets have been set by analysts, with a median target of $18.5 for $RGTI. Benchmark, Needham, B. Riley Securities, and Cantor Fitzgerald have all assigned individual price targets for the stock in recent months, reflecting positive sentiments regarding its potential performance in the market.